OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
31 hedge funds and large institutions have $10.2M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
22% less capital invested
Capital invested by funds: $13.2M → $10.2M (-$2.94M)
Holders
31
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$473K | |
| 2 | +$447K | |
| 3 | +$194K | |
| 4 |
Renaissance Technologies
New York
|
+$194K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$147K |
Top Sellers
| 1 | -$93.9K | |
| 2 | -$57.4K | |
| 3 | -$39K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$19K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14K |